Skip to content

Comparison of fingerprick blood glucose levels and continuous glucose monitoring to assess high and low blood sugar levels in hospitalized patients treated with basal bolus insulin.

Comparison of fingerprick blood glucose levels and continuous glucose monitoring to assess hyper- and hypoglycaemia in hospitalized patients treated with basal bolus insulin.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12611000934943
Enrollment
26
Registered
2011-08-31
Start date
2008-12-01
Completion date
2010-10-30
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The aim is to determine whether 4 fingerprick BGLs routinely performed at nominal times of 0700, 1200, 1700 (these three timeslots are just before meals) and 2100 hours accurately assess the efficacy and safety of basal bolus insulin in hospitalized patients.

Interventions

Determine whether 4 fingerprick capillary blood glucose levels taken at routine sampling times of 0700, 1200, 1700 and 2100 hours over a 24 hour period during a hospital admission, as measured by standard hospital ward glucometers, accurately reflects glucose concentrations determined by continuous glucose monitoring. The duration of sampling will be up to 2 full consecutive days with a minimum of one full day (midnight to midnight). This will be in a population of known diabetic patients receiv

Determine whether 4 fingerprick capillary blood glucose levels taken at routine sampling times of 0700, 1200, 1700 and 2100 hours over a 24 hour period during a hospital admission, as measured by standard hospital ward glucometers, accurately reflects glucose concentrations determined by continuous glucose monitoring. The duration of sampling will be up to 2 full consecutive days with a minimum of one full day (midnight to midnight). This will be in a population of known diabetic patients receiving the standard basal bolus insulin regimen, which is used for patients requiring temporary intensified blood glucose management during admission. Patient recruitment is planned until August 2012.

Sponsors

Repatriation General Hospital
Lead SponsorHospital

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Any hospitalised diabetic inpatient requiring basal-bolus managent for glycaemic control

Exclusion criteria

Unable to provide wrtiien informed consent. Precluded from CGMS use eg requires MRI or abdo surgery during study period

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026